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Abstract
Background: cAMP is an ubiquitous second messenger mediating various neuronal functions,
often as a consequence of increased intracellular Ca2+ levels. While imaging of calcium is commonly
used in neuroscience applications, probing for cAMP levels has not yet been performed in living
vertebrate neuronal tissue before.
Results:  Using a strictly neuron-restricted promoter we virally transduced neurons in the
organotypic brainstem slices which contained pre-Bötzinger complex, constituting the rhythm-
generating part of the respiratory network. Fluorescent cAMP sensor Epac1-camps was expressed
both in neuronal cell bodies and neurites, allowing us to measure intracellular distribution of cAMP,
its absolute levels and time-dependent changes in response to physiological stimuli. We recorded
[cAMP]i changes in the micromolar range after modulation of adenylate cyclase, inhibition of
phosphodiesterase and activation of G-protein-coupled metabotropic receptors. [cAMP]i levels
increased after membrane depolarisation and release of Ca2+ from internal stores. The effects
developed slowly and reached their maximum after transient [Ca2+]i elevations subsided. Ca2+-
dependent [cAMP]i transients were suppressed after blockade of adenylate cyclase with 0.1 mM
adenylate cyclase inhibitor 2'5'-dideoxyadenosine and potentiated after inhibiting
phosphodiesterase with isobutylmethylxanthine and rolipram. During paired stimulations, the
second depolarisation and Ca2+ release evoked bigger cAMP responses. These effects were
abolished after inhibition of protein kinase A with H-89 pointing to the important role of
phosphorylation of calcium channels in the potentiation of [cAMP]i transients.
Conclusion: We constructed and characterized a neuron-specific cAMP probe based on Epac1-
camps. Using viral gene transfer we showed its efficient expression in organotypic brainstem
preparations. Strong fluorescence, resistance to photobleaching and possibility of direct estimation
of [cAMP] levels using dual wavelength measurements make the probe useful in studies of neurons
and the mechanisms of their plasticity. Epac1-camps was applied to examine the crosstalk between
Ca2+ and cAMP signalling and revealed a synergism of actions of these two second messengers.
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Background
cAMP is an ubiquitous second messenger which regulates
a wide variety of cellular events and processes ranging
from metabolism and gene expression, cell division and
migration, exocytosis and secretion, to memory forma-
tion and cardiac contractility [1]. On the one hand, cAMP-
signalling cascades are associated with many vital func-
tions in the CNS that can be exemplified by cAMP-related
changes in neuronal activity [2], dendritic and axonal
growth [3], spine function [4], synaptic activity and neu-
ronal plasticity [5], and gene expression [6] etc. On the
other hand, inadequate cAMP signalling may lead to long-
term disturbances of neuronal functions [7]. cAMP-
dependent enzymes are well characterized in terms of
their affinity, kinetics and mechanisms of their modula-
tion [1]. In order to understand how cAMP-dependent sig-
nalling mechanisms operate in living neurons,
appropriate tools are needed to monitor spatial and time-
dependent changes of cAMP levels.
Direct imaging of cAMP became possible only recently.
Two classes of probes have been developed – one based
on protein kinase A (PKA) and utilizing fluorescence res-
onance energy transfer (FRET) between fluorescein and
rhodamine [8] or CFP and YFP [9], and the other exploit-
ing the exchange protein directly activated by cAMP,
namely Epac [10-12]. PKA-based cAMP probes have slow
response times, making them not very suitable for moni-
toring the rapid changes in [cAMP]i which occur in living
cells. Originally designed Epac has good sensitivity and
temporal resolution [10,11]. Both features are conserved
in Epac-1-camps [12], its smaller size allowing it to be
incorporated into viral vectors with limited genome sizes
such as AAV. In comparison with the common methods
of transfection in primary cultures [13] and organotypic
slices [14], the efficacy of viral gene transfer in postmitotic
neurons is much higher. We recently used adeno-associ-
ated viruses (AAV) driving transgene expression by the
strictly neuron-specific synapsin 1 gene promoter [15] to
selectively express GFP in neurons in organotypic brain-
stem slices [16] containing pre-Bötzinger complex (preB-
ötC), the latter constituting the rhythm-generating part of
the respiratory network [17-19]. An important step in fur-
ther understanding spatial and functional organisation of
the respiratory network now is the expression of fluores-
cent sensors in respiratory neurons and measuring their
responses to physiological stimuli.
Respiratory activity is crucially dependent on cAMP sig-
nalling, which can be dynamically modulated in specific
physiological and pathological conditions [17]. In this
study we aimed to specifically target Epac1-camps to
brainstem neurons. We characterised the sensitivity and
specificity of the sensor to report intraneuronal cAMP. We
measured [cAMP] changes after modulation of adenylate
cyclase (AC), phosphodiesterase (PDE) and activation of
G-protein-coupled metabotropic receptors. [cAMP]
changes were tightly related to calcium transients, which
are important for respiratory rhythmogenesis [20]. Both
depolarisation-triggered Ca2+ entry and agonist-induced
Ca2+  release from endoplasmic reticulum (ER) led to
cAMP increase caused by enhancement of AC activity by
calcium. Paired calcium increases produced a non-linear
summation of subsequent [cAMP]i increases. This was
abolished after PKA inhibition, thus indicating an impor-
tant role for phosphorylation in the dynamic interplay
between Ca2+ and cAMP, previously documented in non-
excitable cells [21].
Results
Application of the AAV-Epac1-camps vector resulted in
expression of the sensor in many neurons per living brain-
stem slice (Fig. 1A). These neurons were arranged into
groups resembling the nuclei characteristic for this section
of the preBötC-containing brainstem [19]. Neuronal
somata displayed brighter fluorescence but neuronal
processes were also distinctly resolvable (Fig. 1B). These
acquisitions sharply contrast to images obtained using
conventional fluorescent calcium probes such as fluo-3
where only the somata of neurons were clearly visible
[16].
The ability of Epac1-camps to register [cAMP]i changes
was first examined in tests where activities of adenylate
cyclase (AC) and phosphodiesterase (PDE) were modu-
lated. Applications of 1 μM forskolin (a specific AC activa-
tor), 50 μM isobutylmethylxanthine (IBMX, non-specific
PDE inhibitor), 1 μM rolipram (a specific inhibitor of
PDE4 [22]), and 0.1 mM 2'5'-dideoxyadenosine (DDA,
membrane-permeable AC inhibitor) induced [cAMP]i
changes in line with the presumed drug targets (Fig. 2,
Table 1). Effects induced by the drugs were reversible and
the responses could be repeatedly elicited after washing-
out for 10 to 15 min. Rolipram was the most effective
among PDE inhibitors – the increases in [cAMP]i induced
by PDE3 inhibitor milrinone (1 μM) and PDE2 inhibitor
EHNA (10 μM) were 0.58 ± 0.05 and 0.21 ± 0.06 μM,
respectively. These effects were smaller than those induced
by rolipram (Table 1) and their magnitude correlates well
with the efficacy of the drugs in cardiomyocytes [23]. The
greater potency of rolipram thus can explain its stimulat-
ing effect on the respiratory motor output in vivo [19]. As
exemplified by the two bottom panels in Fig. 2, activation
of G-protein-coupled receptors produced delayed cAMP
increases, showing the actions of serotonin (5-HT) and
the mGluR1/5 agonist (S)-3,5-dihydroxyphenylglycine
(DHPG). These responses are consistent with the activa-
tion of metabotropic serotonin and glutamate receptors,
respectively.BMC Neuroscience 2009, 10:29 http://www.biomedcentral.com/1471-2202/10/29
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cAMP-signalling pathways are often activated by increases
of calcium levels [1,24]. In order to examine crosstalk
between calcium and cAMP, we loaded the AAV trans-
duced neurons with fura-2 [25] and evoked calcium
changes by applying brief membrane depolarisations with
high-K+  or by inducing calcium release from internal
stores. The first paradigm is similar to the tetanic stimula-
tion often used in the analysis of neuronal plasticity [24].
Fig. 3A illustrates how [cAMP]i started to increase at the
peak of the calcium transient and reached its maximum
during recovery of calcium levels to the resting value. Cal-
cium release from ER induced by activation of metabo-
tropic P2Y receptors with 1 mM ATP [26] also led to
delayed [cAMP]i increases. Their amplitude and duration
were similar to those induced by membrane depolarisa-
tion (Fig. 3A).
Various isoforms of AC and PDE are known to be differ-
entially activated by calcium [21]. Ca2+-dependent stimu-
lation of PDE would decrease [cAMP]i, therefore the
effects observed indicate a dominating role of AC modu-
lation in Ca2+-dependent increases. After blockade of AC
activity with DDA, the amplitude of [Ca2+]i transients
became smaller (Fig. 3B, Table 2), indicating that a
decrease in production of cAMP can promote dephospho-
rylation of Ca2+ channels leading to a decrease in their
activity [28]. Conversely, calcium transients were signifi-
cantly increased after a blockade of PDE (Fig. 3C, Table 2)
that causes stimulation of PKA and subsequent phospho-
rylation of the channels (see also below).
Removal of extracellular Ca2+ or introduction of 0.1 mM
Cd2+, which blocks all pathways for Ca2+ entry into the
cell, abolished depolarisation-induced [cAMP]i changes
(Table 2). The blockade of Ca2+ entry did not modify the
effects of ATP (Fig. 3D). This indicates that only calcium
release after activation of metabotropic P2y receptors is
important and ionotropic P2X receptors are not involved
in ATP-induced [cAMP]i  increases. The effects were
occluded after depletion of ER with thapsigargin (Table
2). This treatment also reduced the effects caused by mem-
brane depolarisations by about 1/3 (Fig. 3D, Table 2)
indicating contribution of Ca2+-induced Ca2+  release
(CICR [29]) to [cAMP]i responses.
It was recently found in presynaptic boutons of Dro-
sophila neurons [30] that Ca2+-related Epac1-camps
responses can be mediated by changes in [cGMP]i. This
apparently contradicts the fact that the affinity of the sen-
sor to cGMP (Kd = 11 μM) is by about one order of mag-
nitude lower than that for cAMP [12]. However, the
presynaptic calcium transients may have considerably
higher amplitude and cause AC inactivation (see Discus-
sion) which would make [cGMP]i changes dominant. In
order to examine whether cGMP changes can underlie, in
part, the responses of Epac1-camps, we applied guanylyl
cyclase inhibitor 1H-[1,2,4]-oxadiazolo- [4,3-a]-quinoxa-
lin-1-one (ODQ, 100 μM), the NOS inhibitor N-mono-
methyl-L-arginine (L-NMMA), and the NO donor S-
nitroso-N-acetylpenicillamine (SNAP, 300 μM). These
drugs were applied at concentrations at which they
showed distinct effects on the respiratory motor output in
Expression of neuron-specific Epac1-camps Figure 1
Expression of neuron-specific Epac1-camps. Representative original images of AAV-Epac1-camps-transduced organotypic 
slice (A) which contained pre-Bötzinger complex (preBötC) and other characteristic nuclei (XII – Nucleus hypoglossus, NTS – 
Nucleus tractus solitarii, IO – inferior olive, Sp5 – spinal nucleus) and neurons in preBötC (B). The images were acquired at 
×10 (A) and ×40 (B) magnification.BMC Neuroscience 2009, 10:29 http://www.biomedcentral.com/1471-2202/10/29
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Characteristic [cAMP] changes in preBötC neurons Figure 2
Characteristic [cAMP] changes in preBötC neurons. Shown are representative responses (for the statistics, see Table 
1) due to modulation of activity of adenylate cyclase, phosphodiesterase and activation of metabotropic receptors. AC was 
stimulated with forskolin and inhibited with 2'5'-dideoxyadenosine (DDA), PDE was antagonized with IBMX and rolipram, and 
Group I metabotropic glutamate receptors were activated with (S)-3,5-dihydroxyphenylglycine (DHPG). Fluorescence signals 
were averaged over the soma of neurons and transformed into cAMP concentrations as described in Methods.
Table 1: Mean [cAMP]i changes observed after modulation of cAMP signalling pathway and activation of G-protein coupled glutamate 
and serotonin receptors
Forskolin
1 μM
IBMX
50 μM
DDA
100 μM
Rolipram
1 μM
DHPG
100 μM
5-HT
2 μM
1.62 ± 0.12 1.45 ± 0.07 -0.12 ± 0.05 1.19 ± 0.08 0.74 ± 0.07 0.81 ± 0.05
Mean data ± S. E. M. were obtained in 4 to 8 neurons in four different preparations and are presented as changes from the resting cAMP level 
(mean = 0.09 ± 0.03 μM). Group I metabotropic glutamate receptors (mGluR1/5) were activated with (S)-3,5-dihydroxyphenylglycine (DHPG).BMC Neuroscience 2009, 10:29 http://www.biomedcentral.com/1471-2202/10/29
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Interrelationships between calcium and cAMP transients measured with fura-2 and Epac-1-camps Figure 3
Interrelationships between calcium and cAMP transients measured with fura-2 and Epac-1-camps. Cytoplasmic 
calcium and cAMP (grey and black traces, respectively) were recorded with fura-2 and Epac-1-camps during testing challenges 
to 50 mM K+ and 1 mM ATP as indicated. Mean peak responses are given in Table 2. The applications were made in control (A) 
and then in the presence of 0.1 mM DDA (B) and 50 μM IBMX (C) to inhibit the activity of adenylate cyclase and phosphodi-
esterase, respectively. Note the changes in the amplitude of both calcium and cAMP transients after the treatments. The two 
panels in (D) show the responses in [Ca2+]i and [cAMP]i which were recorded 10 min after preincubation with 1 μM thapsi-
gargin to deplete calcium stores (left) and in Ca2+-free solution to inhibit calcium influx (right).BMC Neuroscience 2009, 10:29 http://www.biomedcentral.com/1471-2202/10/29
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vivo [31], but they did not modify the signals of Epac1-
camps (n = 3 for each treatment).
We observed a mutual interference between Ca2+ and
cAMP signalling pathways. Application of paired stimuli
produced bigger [cAMP]iresponses during the second
stimulation which increased calcium (Fig. 4A). Such
enhancement of the response can be mediated by Ca2+-
driven stimulation of PKA increasing the activity of volt-
age-sensitive Ca2+channels [4,26]. In order to test this
assumption, we applied PKA inhibitor H-89 (N- [2-(p-
bromocinnamylamino)ethyl]-5-isoquinoline sulfona-
mide hydrochloride, 10 μM for 10 min). After pretreat-
ment with H-89, the potentiation of secondary [Ca2+]i and
[cAMP]iincreases was abolished (Fig. 4A). The enhance-
ment of [cAMP]i responses was also observed after cal-
cium release from ER and corresponding effects were
inhibited by H-89 (Fig. 4B, C).
Discussion
Many vitally important processes which determine the life
and fate of neurons are controlled by cAMP and Ca2+,
which often act in parallel [1]. In non-excitable cells the
fluctuations of [Ca2+]i and [cAMP]i are often interrelated
[32] and linked via adenylate cyclase [21] or phosphodi-
esterase [21]. AC has eight different isoforms which can be
stimulated and inhibited by Ca2+. The stimulation is char-
acteristic for AC1 and AC8 which are abundant in the
brain and activated by calmodulin. All AC isoforms are
inhibited by supramicromolar concentrations of Ca2+ (>
10 μM) binding to a low-affinity site in the catalytic AC
domain [21]. We recorded calcium transients of much
smaller amplitude, therefore a Ca2+-mediated inhibition
of AC should not play any significant role in the effects
reported here. It may however become significant in
domains which are located close to the exit of Ca2+ from
the channels producing calcium gradients which can
reach values as high as 100 μM [33] and locally limit the
production of cAMP.
The levels of Ca2+ and cAMP are often changed by various
neurotransmitters and [cAMP]i changes may be further
differentially decoded downstream through, for example,
PKA, Epac, cAMP-binding protein (CREB) and Rap to ini-
tiate events such as gene expression and cell differentia-
tion. PKA-mediated phosphorylation of channels is
important for normal functioning of the channels that
mediate entry of Ca2+ into the cytoplasm and its release
from internal stores. These phosphorylation/dephospho-
rylation reactions thus close a regulatory Ca2+/cAMP feed-
back.
In comparison to Ca2+, we currently know much less
about the changes in intracellular cAMP which can occur
in relation to neuronal activity. Increasing applications of
cAMP sensors developed in the last decade [8-12] to dif-
ferent neuronal preparations will definitely bring new
knowledge in this area. Although until now such studies
have been made only in some cell lines [34] and isolated
neurons in primary culture [35], they have already
revealed the complexity of cAMP dynamics. The neurons
in living tissue present the next level of sophistication, as
their properties can be modified by interactions with
neighbouring neurons and surrounding glial cells. Intrin-
sic electrical activity of neurons add another important
factor, because ensuing calcium fluxes of different ampli-
tude and time-courses and spontaneous calcium release
from internal stores should substantially modulate spatial
[cAMP]i patterns on different time scales. How they are
involved in different vital cellular functions such as neu-
ronal plasticity, differentiation and development remains
to be established.
Currently available cAMP sensors are bulky proteins and
the first obstacle in cAMP imaging concerns the delivery of
Table 2: Mean peak [Ca2+]i and [cAMP]i increases due to membrane depolarisation and Ca2+ release applications in the presence of 
drugs modulating cAMP and Ca2+ homeostasis.
Intracellular variable Control IBMX
50 μM
DDA
100 μM
Thapsigargin
2 μM
0 Ca2+
High-K+
50 mM
[Ca2+]i 0.44 ± 0.07 0.72 ± 0.08 0.24 ± 0.06 0.31 ± 0.05 0.01 ± 0.01
[cAMP]i 1.52 ± 0.09 3.22 ± 0.17 0.25 ± 0.02 0.94 ± 0.08 0.04 ± 0.01
ATP
1 mM
[Ca2+]i 0.39 ± 0.07 0.52 ± 0.08 0.24 ± 0.06 0.01 ± 0.01 0.31 ± 0.05
[cAMP]i 1.44 ± 0.08 2.24 ± 0.07 0.36 ± 0.03 0.04 ± 0.01 1.42 ± 0.08
Mean data ± S. E. M. were obtained in 4 to 8 neurons in four different preparations. Thapsigargin and Ca2+-free solution were applied for 10 min 
before the treatments.BMC Neuroscience 2009, 10:29 http://www.biomedcentral.com/1471-2202/10/29
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the probe into the cytoplasm. A straightforward way is a
single cell injection [8] with well known difficulties.
Transgenic animals would be an ideal solution and this
approach has been successfully used to study cAMP sig-
nalling in the heart [23], pancreatic islets [36] and the
neurons of fruit-flies [37]. Non-cytotoxic viral gene trans-
fer presents an alternative not limited in its application by
the animal or tissue [15,38]. It can be applied to any cell
population given that the sensor is targeted to the specific
cell type. We used a strictly neuron-specific promoter [15]
to deliver the cAMP sensor [12] into neurons in slices. As
a proof of concept, we showed that Epac1-camps is
expressed in many neurons and reports [cAMP]i levels and
their fluctuations in μM range after various physiological
stimuli. We observed that membrane depolarisation and
calcium release from internal stores produced [cAMP]i
increases that led to further enhancement of calcium entry
or calcium release through PKA-dependent phosphoryla-
tion. The effects were observed after relatively long-lasting
calcium increases similar to those evoked by the tetanic
stimulation commonly used to induce a long-term poten-
tiation [24]. The concerted actions of the two second mes-
sengers can convey specific messages between neurons but
Ca2+ and cAMP should have different spatial and temporal
ranges of actions. For example, the production and con-
sumption rates of cAMP as well as its diffusion coefficient
(Nikolaev et al. 2004) are more consistent with slower
and spatially extended changes, whereas the actions of
Ca2+ must be faster and more localised. How the effects of
these two second messengers are orchestrated, and how
they influence the neuronal activity, represents a challeng-
ing task for future studies. We believe that neuronal spe-
Non-linear interactions between Ca2+ influx and Ca2+ release during [cAMP] increases Figure 4
Non-linear interactions between Ca2+ influx and Ca2+ release during [cAMP] increases. Testing applications of 50 
mM K+ and 100 μM ATP were made as indicated by horizontal bars. Changes in [Ca2+]i and [cAMP]i are shown by grey and 
black traces, respectively. The experiments were performed in control (left) and repeated 20 min after pretreatment with pro-
tein kinase A inhibitor H-89 (10 μM, right). A – Two depolarisation with high K+. B – Ca2+ release from ER with following depo-
larisation. C – Depolarisation and Ca2+ release. Note that potentiation of [cAMP] increases during the second treatments was 
abolished by H-89.BMC Neuroscience 2009, 10:29 http://www.biomedcentral.com/1471-2202/10/29
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cificity, optical stability and sensitivity of Epac1-camps-
based sensor provide a solid platform for such examina-
tions.
Conclusion
We here report the application of Epac1-camps to meas-
ure cAMP concentrations in mammalian neurons embed-
ded in their three dimensional context in living tissue. The
sensitivity and specificity of neuron-targeted Epac1-camps
are characterized and the probe was applied to examine
crosstalk between calcium and cAMP signalling in brain-
stem neurons.
Methods
All animals were housed, cared for and euthanized in
accordance with the recommendations of the European
Commission (No. L358, ISSN 0378-6978), and protocols
approved by the Committee for Animal Research, Göttin-
gen University. Organotypic culture slices were obtained
as described previously [16]. Briefly, we prepared 250 μm-
thick brainstem slices following a conventional procedure
to obtain so called 'rhythmic slices' [17,20,30,37]. All
slices contained typical anatomy markers as documented
in the atlas of the brainstem [19].
After preparation slices were placed on support mem-
branes (Millicell-CM Inserts, PICMORG50; Millipore). 1
ml medium added to let the surface of the slice be contin-
uously exposed to the incubator gas mixture and the
medium (50% MEM with Earle's salts, 25 mM Hepes, 6.5
mg/ml glucose, 25% horse serum, 25% Hanks solution
buffered with 5 mM Tris and 4 mM NaHCO3, pH 7.3)
changed every second day. During the experiments, each
slice was fixed on a coverslip mounted in the recording
chamber and was continuously superfused at 34°C with
artificial cerebro-spinal fluid (ACSF). Under experimental
conditions the bath solution was fully exchanged within 1
s for different periods of time ranging from 10 s (applica-
tions of 50 mM K+, 100 μM ATP) to 2 min (forskolin,
IBMX, DDA, rolipram etc.). High-K+ solution was pre-
pared by exchanging Na+in ACSF; all other testing solu-
tions were produced by adding aliquots of corresponding
stock solutions directly to ACSF at approx. 1000-fold dilu-
tion.
Neurons in slices were transduced with AAV-Epac1-camps
which expressed the sensor under control of the strictly
neuron-specific synapsin 1 gene promoter [15]. 1 μl of
AAV solution (≈ 1 × 109 viral genomes) was applied
directly onto the slice surface. Epac1-camps expression
reached a steady state two days after viral application and
did not change afterwards. Each test in the study was
repeated with at least four different preparations, 4 to 8
neurons in each image field were examined.
The optical recording system was based on a Zeiss Axio-
scope and the slices were viewed under a 10× (Achroplan,
N. A. 0.10) or 40× objective (Achroplan, N. A. 0.8). Epac1-
camps was excited at 430 nm by the light generated by
LED (20 mW, Roithner Lasertechnik). CFP emission at
470 nm and FRET between CFP and YFP (emitted at 535
nm) were separated with Optosplit (BFI Optilas, Puch-
heim) using dichroic mirror at 495 nm and 470 ± 12 and
535 ± 15 nm filters, respectively. Bleaching of Epac1-
camps was negligible, thus allowing us to record fluores-
cence for more than 60 min without substantial loss of the
signal. Images were captured by a cooled CCD camera
(ANDOR, Offenbach) and collected with ANDOR soft-
ware (500 × 500 pixels at 12 bit resolution). Time-
dependent changes were obtained offline using Meta-
Morph software (Princeton Instruments, USA). The data
were collected in the regions of interest which encircled
the soma of neurons.
[cAMP] values were obtained from the ratio of Epac1-
camps fluorescence (R) excited at 430 nm and emitted at
535 nm (FRET) and 470 nm (CFP). Fig. 5A presents cali-
bration of cAMP levels in vivo using membrane-permeable
8-Bromo-2'-O-methyl-cAMP (BrOMecAMP), a specific
activator of Epac [39]. Measured ratio changes (R) were
well fitted with the Michaelis-Menten-like equation
where C is the concentration of nucleotide and Kd is the
dissociation constant for Epac1-camps (Fig. 5B). In esti-
mating Rmax we accounted for the basal [cAMP] level by
suppressing AC activity with DDA (see Results). Absolute
cAMP levels were obtained as
The basal [cAMP]i was 0.09 ± 0.03 μM (n = 16), corre-
sponding to the lower branch of the dose-response curve
in Fig. 5B, and all [cAMP]i observed changes were well
below 5 μM (Tables 1 and 2), indicating that the probe
has an optimal dynamic range for imaging cAMP in neu-
rons. From Eqs. (1) and (2) follows that [cAMP] is approx-
imately proportional to the measured ratio for [cAMP]
levels when they are below Kd of the sensor (1.5 μM).
Because this condition is not always fulfilled, presentation
of [cAMP] changes in the ratio form may show erroneous
kinetics.
Epac1-camps also was calibrated in vitro using previously
described procedures [12]. Briefly, HEK293 cells were
transfected with Epac1-camps. 24 h after transfection,
cells were washed three times and resuspended in 5 mM
R
RmaxC
Kd C
=
+
(1)
C
KdR
Rmax R
=
−
(2)BMC Neuroscience 2009, 10:29 http://www.biomedcentral.com/1471-2202/10/29
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Calibration of cAMP levels in neurons Figure 5
Calibration of cAMP levels in neurons. A– Increases in 470/535 nm emission ratio during sequential additions of specific 
membrane-permeable Epac agonist 8-Bromo-2'-OMe-cAMP. B – Calibration of Epac-1-camps. Mean ratios ± S. E. M were 
obtained for 8-Bromo-2'-OMe-cAMP in vivo and in vitro, and for cAMP in vitro. The data are plotted against nucleotide concen-
tration and the smooth curve was drawn according to the Michaelis – Menten-like equation with Kd = 1.5 μM. C – Typical 
Ca2+-dependent changes in [cAMP] after membrane depolarisation. Shown are the raw traces of Epac-1-camps emission at 470 
nm (CFP) and 535 nm (FRET) excited at 430 nm and of fura-2 emission at 535 nm excited at 350 and 380 nm as indicated. The 
lower two traces demonstrate changes in the fura-2 ratio at excitation wavelengths 350 and 380 nm and those obtained after 
subtraction of 15% of Epac1-camps signal (Ex 430 nm, Em 535 nm) from fura-2 signal (Ex 380, Em 535 nm).BMC Neuroscience 2009, 10:29 http://www.biomedcentral.com/1471-2202/10/29
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Tris, 2 mM EDTA, pH 7.4 buffer. After disruption with an
Ultraturrax device for 40 s on ice and 20 min centrifuga-
tion at 80000 rpm, fluorescence emission spectra of the
supernatant (excitation at 436 nm, emission range 460 –
550 nm) were measured with a fluorescence spectrometer
LS50B (Perkin Elmer Life Sciences) before and after addi-
tion of cAMP and BrOMecAMP (Biolog Life Science Insti-
tute, Bremen, Germany) at various concentrations. The
concentration of Epac1-camps protein was 50 nM. FRET/
CFP ratios were calculated by dividing peak emission
intensities at 524 nm (FRET) and 477 nm (CFP) and ana-
lyzed by Origin 6.1 (Origin Lab Corporation, Northamp-
ton, MA). The use of emission wavelengths with wider
slits such as set up in an Optosplit gave similar ratios. The
curves for BrOMecAMP in vivo and in vitro were identical
and were close to the dose-response curve obtained for the
sensor in slices (Fig. 5B). Kd values in vivo and in vitro were
1.6 and 1.5 μM for BrOMecAMP, respectively, and 1.2 μM
for cAMP.
For imaging of intracellular calcium, 3 μM fura-2/AM was
added to ACSF as an aliquot of DMSO-based stock solu-
tion and the mixture was sonicated. Slices were incubated
with the dye for 20 min at 37°C followed by a 30 min-
long wash-out to allow deesterification of ester precursor.
Fura-2 was excited at 350 and 380 nm, and the emission
was collected at 535 nm. [Ca2+]i values were obtained as
described previously [40].
During simultaneous calcium and cAMP imaging we
made concerns on possible contamination of the
recorded fura-2 signal by CFP fluorescence from Epac1-
camps which can be also excited by UV [25]. Fig. 5C
shows the two pairs of Epac1-camps (470 and 535 nm
emission at 430 nm excitation) and fura-2 signals (535
nm emission at 350 and 380 nm excitation), which were
recorded during high-K+  stimulation. Imaging of cells
which were not loaded with fura-2 showed that excitation
of CFP at 380 nm produced the fluorescence at 535 nm
which is only 10 ± 2% (n = 24) of that recorded at 430 nm
excitation. This estimate agrees well with the excitation
spectrum of Epac1-camps in vitro [12]. The two lowermost
traces in Fig. 5C show the effect of possible bleeding of
Epac1-camps fluorescence into the fura-2 channel. Sub-
traction of 15% Epac1-camps signal (Ex 430 nm, Em 535
nm) taken as an upper limit for bleeding to fura-2 channel
(Ex 380 nm, Em 535 nm) did not change the traces signif-
icantly.
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